Shenzhen Jinrui Kaili Biotechnology Co., Ltd.

Jinrui Kaili was founded in 2007 and joined Weigao Group in 2015. It is an innovative high-tech enterprise specializing in the research and development, production, and sales of cardiovascular minimally invasive interventional medical device products. The company is located on floors 3-5 of Building B1, Qimeng Smart Park, No. 28 Youtian Road, Anliang Community, Yuanshan Street, Longgang District, covering an area of 7,500 square meters. Its main business is the research and development, production, and sales of medical device products, including Class III medical devices. The company emphasizes independent innovation and has developed a high-tech product with independent intellectual property rights—the Helios drug-eluting stent—bringing more hope to patients and laying a solid foundation for China's coronary intervention industry to be at the forefront of the world. The company is the first enterprise in South China to obtain a product registration certificate for a drug-eluting stent system, promoting the optimization and upgrading of the industrial structure, enhancing industrial competitiveness, and accelerating its pace of participation in domestic and international competition.